UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Legionella Anti-autophagy Effector RavZ Targets the Autophagosome via PI3P- and Curvature-Sensing Motifs

Developmental cell, 2015-09, Vol.34 (5), p.569-576

2015

Volltextzugriff (PDF)

Iron and manganese fluxes across the sediment-water interface in a drinking water reservoir

Water research (Oxford), 2020-09, Vol.182, p.116003-116003, Article 116003

2020

Volltextzugriff (PDF)

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2023-06, Vol.388 (26), p.2444-2455

2023

Volltextzugriff (PDF)

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Journal of the American College of Cardiology, 2015-11, Vol.66 (20), p.2201-2210

2015

Volltextzugriff (PDF)

Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study

European heart journal, 2016-05, Vol.37 (17), p.1360-1369

2016

Volltextzugriff (PDF)

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2011-11, Vol.306 (19), p.2099

2011

Volltextzugriff (PDF)

Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction

The American journal of cardiology, 2022-08, Vol.176, p.79-88

2022

Volltextzugriff (PDF)

Population Pharmacokinetics (PK) and Pharmacodynamics (PD) Analysis of LY3015014, a Monoclonal Antibody to Protein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Healthy Subjects and Hypercholesterolemia Patients

Pharmaceutical research, 2017, Vol.34 (1), p.185-192

2017

Volltextzugriff (PDF)

Ecosystem-Scale Oxygen Manipulations Alter Terminal Electron Acceptor Pathways in a Eutrophic Reservoir

Ecosystems (New York), 2021-09, Vol.24 (6), p.1281-1298

2021

Volltextzugriff (PDF)

Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia

The American journal of cardiology, 2014-06, Vol.113 (12), p.2021-2029

2014

Volltextzugriff (PDF)

Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial

The American journal of psychiatry, 2005-04, Vol.162 (4), p.683-690

2005

Volltextzugriff (PDF)

Mitochondrial bioenergetics and D-ribose in HFpEF: a brief narrative review

Annals of translational medicine, 2021-10, Vol.9 (19), p.1504-1504

2021

Volltextzugriff (PDF)

Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults

Journal of pharmacy and pharmacology, 2014-11, Vol.66 (11), p.1576-1585

2014

Volltextzugriff (PDF)

Understanding Obesity-Related High Output Heart Failure and Its Implications

International Journal of Heart Failure, 2021, 3(3), , pp.160-

2021

Volltextzugriff (PDF)

Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients

Journal of clinical lipidology, 2016-05, Vol.10 (3), p.519-527.e4

2016

Volltextzugriff (PDF)

Utilizing Real-time Technology to Assess the Impact of Home Environmental Exposures on Asthma Symptoms: Protocol for an Observational Pilot Study

JMIR research protocols, 2022-08, Vol.11 (8), p.e39887

2022

Volltextzugriff (PDF)

Clinical trial visits in the age of COVID-19: implementation of research participant safety measures

International Journal of Clinical Trials, 2021-04, Vol.8 (2), p.167

2021

Volltextzugriff (PDF)

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

Breast cancer research and treatment, 2001, Vol.65 (2), p.125-134

2001

Volltextzugriff (PDF)

Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction

Annals of medicine and surgery, 2020-07, Vol.55, p.77-80

2020

Volltextzugriff (PDF)

Evacetrapib at a Supratherapeutic Steady State Concentration Does Not Prolong QT in a Thorough QT/QTc Study in Healthy Participants

Journal of cardiovascular pharmacology and therapeutics, 2014-05, Vol.19 (3), p.283-289

2014

Volltextzugriff (PDF)

Serum estradiol level and risk of breast cancer during treatment with raloxifene

JAMA : the journal of the American Medical Association, 2002-01, Vol.287 (2), p.216

2002

Volltextzugriff (PDF)

CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome

British journal of clinical pharmacology, 2015-12, Vol.80 (6), p.1388-1398

2015

Volltextzugriff (PDF)

The metabolic syndrome and development of cognitive impairment among older women

Archives of neurology (Chicago), 2009-03, Vol.66 (3), p.324

2009

Volltextzugriff (PDF)

Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants

Journal of clinical oncology, 2001-06, Vol.19 (12), p.3111-3116

2001

Volltextzugriff (PDF)

Arthropod Innate Immune Systems and Vector-Borne Diseases

Biochemistry (Easton), 2017-02, Vol.56 (7), p.907-918

2017

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(138)
Deutsch
(1)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Legionella Anti-autophagy Effector RavZ Targets the Autophagosome via PI3P- and Curvature-Sensing Motifs

Iron and manganese fluxes across the sediment-water interface in a drinking water reservoir

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial

Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction

Population Pharmacokinetics (PK) and Pharmacodynamics (PD) Analysis of LY3015014, a Monoclonal Antibody to Protein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Healthy Subjects and Hypercholesterolemia Patients

Ecosystem-Scale Oxygen Manipulations Alter Terminal Electron Acceptor Pathways in a Eutrophic Reservoir

Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia

Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial

Mitochondrial bioenergetics and D-ribose in HFpEF: a brief narrative review

Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults

Understanding Obesity-Related High Output Heart Failure and Its Implications

Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients

Utilizing Real-time Technology to Assess the Impact of Home Environmental Exposures on Asthma Symptoms: Protocol for an Observational Pilot Study

Clinical trial visits in the age of COVID-19: implementation of research participant safety measures

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction

Evacetrapib at a Supratherapeutic Steady State Concentration Does Not Prolong QT in a Thorough QT/QTc Study in Healthy Participants

Serum estradiol level and risk of breast cancer during treatment with raloxifene

CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome

The metabolic syndrome and development of cognitive impairment among older women

Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants

Arthropod Innate Immune Systems and Vector-Borne Diseases

Suchergebnisse filtern